Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hecht

Showing results (911-920 of 925) with videos related to

Pageof 93
Sort By:
Critical Reviews in Toxicology|December 5, 2023
From cultivation to cancer: formation of <i>N</i>-nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implicationsStephen B Stanfill, Stephen S Hecht, Andreas C Joerger, et al.
Journal of Pharmaceutical Sciences|March 2, 2021
Discovery of a dual pathway aggregation mechanism for a therapeutic constrained peptideTao Chen, Shijia Tang, Elizabeth S Hecht, et al.
Journal of Exposure Science & Environmental Epidemiology|February 19, 2020
Opportunities for evaluating chemical exposures and child health in the United States: the Environmental influences on Child Health Outcomes (ECHO) ProgramJessie P Buckley, Emily S Barrett, Paloma I Beamer, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 20, 2017
Biomarkers of exposure to new and emerging tobacco delivery productsSuzaynn F Schick, Benjamin C Blount, Peyton Jacob, et al.
The American Journal of Cardiology|July 18, 2006
From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force reportMorteza Naghavi, Erling Falk, Harvey S Hecht, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2020
Biomarkers of Exposure among Adult Smokeless Tobacco Users in the Population Assessment of Tobacco and Health Study (Wave 1, 2013-2014)Yu-Ching Cheng, Carolyn M Reyes-Guzman, Carol H Christensen, et al.
The New England Journal of Medicine|October 1, 2015
Randomized Trial of Reduced-Nicotine Standards for CigarettesEric C Donny, Rachel L Denlinger, Jennifer W Tidey, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNKMichael Korenjak, N Alpay Temiz, Stéphane Keita, et al.
Genome Medicine|July 3, 2026
Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNKMichael Korenjak, Nuri Alpay Temiz, Stéphane Keita, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 13, 2021
Serum Concentrations of Cotinine and Trans-3'-Hydroxycotinine in US Adults: Results From Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health StudyConnie S Sosnoff, Kevin Caron, J Ricky Akins, et al.
Pageof 93

Showing results (911-920 of 925) with videos related to

Sort By:
Pageof 93
Critical Reviews in Toxicology|December 5, 2023
From cultivation to cancer: formation of <i>N</i>-nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implicationsStephen B Stanfill, Stephen S Hecht, Andreas C Joerger, et al.
Journal of Pharmaceutical Sciences|March 2, 2021
Discovery of a dual pathway aggregation mechanism for a therapeutic constrained peptideTao Chen, Shijia Tang, Elizabeth S Hecht, et al.
Journal of Exposure Science & Environmental Epidemiology|February 19, 2020
Opportunities for evaluating chemical exposures and child health in the United States: the Environmental influences on Child Health Outcomes (ECHO) ProgramJessie P Buckley, Emily S Barrett, Paloma I Beamer, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 20, 2017
Biomarkers of exposure to new and emerging tobacco delivery productsSuzaynn F Schick, Benjamin C Blount, Peyton Jacob, et al.
The American Journal of Cardiology|July 18, 2006
From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force reportMorteza Naghavi, Erling Falk, Harvey S Hecht, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2020
Biomarkers of Exposure among Adult Smokeless Tobacco Users in the Population Assessment of Tobacco and Health Study (Wave 1, 2013-2014)Yu-Ching Cheng, Carolyn M Reyes-Guzman, Carol H Christensen, et al.
The New England Journal of Medicine|October 1, 2015
Randomized Trial of Reduced-Nicotine Standards for CigarettesEric C Donny, Rachel L Denlinger, Jennifer W Tidey, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNKMichael Korenjak, N Alpay Temiz, Stéphane Keita, et al.
Genome Medicine|July 3, 2026
Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNKMichael Korenjak, Nuri Alpay Temiz, Stéphane Keita, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 13, 2021
Serum Concentrations of Cotinine and Trans-3'-Hydroxycotinine in US Adults: Results From Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health StudyConnie S Sosnoff, Kevin Caron, J Ricky Akins, et al.
Pageof 93